Trials / Completed
CompletedNCT03196804
A Phase I Clinical Trial to Investigate the Safety, Tolerability and Pharmacokinetic Characteristics of LC28-0126.
A Dose Blocked-randomized, Double-blind, Placebo-controlled, Multiple Dosing and Dose-escalation Phase I Clinical Trial to Investigate the Safety, Tolerability and Pharmacokinetic Characteristics of LC28-0126 in Healthy Male Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 32 (actual)
- Sponsor
- LG Chem · Industry
- Sex
- Male
- Age
- 19 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
To assess the safety, tolerability and pharmacokinetic characteristics of LC-28-0126 multiple iv injection in healthy male subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | LC28-0126 | LC28-0126 |
| DRUG | Placebo | Placebo |
Timeline
- Start date
- 2017-06-07
- Primary completion
- 2017-11-15
- Completion
- 2017-11-15
- First posted
- 2017-06-23
- Last updated
- 2018-04-11
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT03196804. Inclusion in this directory is not an endorsement.